Lifeng Li
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 14
- Advanced biosensing and bioanalysis techniques 12
- Gut microbiota and health 9
-
- Cancer, Hypoxia, and Metabolism 10
- Cancer-related molecular mechanisms research 8
- Co-authors
- Jie Zhao (40 shared papers)Wenhua Xue (33 shared papers)Zhibo Shen (22 shared papers)Yi Zhang (14 shared papers)Wancun Zhang (29 shared papers)Zhirui Fan (22 shared papers)Xinwei Han (15 shared papers)Xianfei Ding (14 shared papers)
- Journals
- Scientific Reports (7 papers)Medicine (6 papers)Oncotarget (5 papers)Cellular Physiology and Biochemistry (5 papers)Frontiers in Immunology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lifeng Li
261 papers receiving 5.3k citations
Lifeng Li's Hit Papers
Peers
Comparison fields: 5 of 189
- Molecular Medicine 230
- Cancer Research 561
- Immunology 630
- Oncology 715
- Molecular Biology 1.7k
Countries citing papers authored by Lifeng Li
This map shows the geographic impact of Lifeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Li more than expected).
Fields of papers citing papers by Lifeng Li
This network shows the impact of papers produced by Lifeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Li. The network helps show where Lifeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lifeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 282 | |
| 2 | Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy Hit paper breakdown → | 2022 | 173 |
| 3 | 2019 | 154 | |
| 4 | 2022 | 132 | |
| 5 | 2023 | 93 | |
| 6 | 2009 | 93 | |
| 7 | Breakthrough of solid tumor treatment: CAR-NK immunotherapy Hit paper breakdown → | 2024 | 92 |
| 8 | 2023 | 85 | |
| 9 | 2017 | 84 | |
| 10 | 2021 | 84 | |
| 11 | 2019 | 81 | |
| 12 | 2014 | 81 | |
| 13 | 2018 | 81 | |
| 14 | 2020 | 79 | |
| 15 | 2018 | 74 | |
| 16 | 2018 | 72 | |
| 17 | 2016 | 72 | |
| 18 | 2020 | 71 | |
| 19 | 2012 | 65 | |
| 20 | 2019 | 64 |
About Lifeng Li
Lifeng Li is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 275 papers that have together received 5.4k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (20 papers), RNA modifications and cancer (14 papers), Metal-Organic Frameworks: Synthesis and Applications (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Cancer, Hypoxia, and Metabolism (10 papers), Gut microbiota and health (9 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Molecular Medicine (230 citations), Cancer Research (561 citations), Immunology (630 citations), Oncology (715 citations) and Molecular Biology (1.7k citations). Lifeng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jie Zhao, Wenhua Xue, Zhibo Shen, Yi Zhang, Wancun Zhang, Zhirui Fan, Xinwei Han, Xianfei Ding, Chaoqi Zhang and Liping Wang. Their work appears in journals such as Scientific Reports, Medicine, Oncotarget, Cellular Physiology and Biochemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.